Related Experiment Video
Updated: Jul 26, 2026

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
Published on: September 22, 2011
Industrial choices for protein production by large-scale cell culture
1Bioprocess R&D, Merck Research Laboratories, Merck & Co, Inc, PO Box 2000, Rahway, NJ 07065, USA. lily_chu@merck.com
Abstract:
Traditional barriers to large-scale mammalian culture have now been addressed, with the standard stirred-tank reactor emerging as industry's technology of choice. The issues of adapting cells to suspension culture, shear sensitivity and oxygen supply have been largely resolved. But for many low-volume and specialty applications, such as the production of viral vaccines and gene therapies, reactor technology remains diversified, with reactor types ranging from roller bottles to stacked plates and hollow fibers.
More Related Videos
Related Concept Videos
Bioreactor Design and Operational System
Bioreactor Controls-III
Scale-Up Processes
Upstream Processing
Production of Antibiotics
Production of Pharmaceuticals

